CME Institute Activities

Additional stories

This week begins with a look at opioid use disorder data, a dive into mild cognitive impairment, and a roundup of bipolar disorder research.
The Florida State University study reveals that aspartame may have negative effects on memory and cognitive abilities in mice, with potential hereditary implications.
A nine-year UK Biobank study identifies seven habits that can reduce depression risk by 57%.
In his new book, Richard Brockman, MD discusses how his career in psychiatry has been deeply influenced by his own mother's suicide.
MDMA-assisted therapy could be a significant new treatment option for moderate-to-severe PTSD.
This week begins with a look at opioid use disorder data, a dive into mild cognitive impairment, and a roundup of bipolar disorder research.
Target genes and vulnerable cell types for potential autism treatments emerge from the research.
A new diagnostic approach using the Single-Cell Raman platform offers hope for precise ME/CFS diagnosis and potential applications in other chronic fatigue conditions.
Intravenous ketamine emerges as an equally effective and more cost-efficient alternative to FDA-approved intranasal esketamine for treating Treatment-Resistant Depression.